A Drug Recall That Should Frighten Us All About The FDA – Forbes

forbes  David Maris, Contributor I care about healthcare trends, innovation, and healthcare stocks. Pay attention, as I can’t say this seriously enough. Last week, the FDA took a drug off the market, and the reasons should send shivers of fear down the backs of consumers, investors, generic drug companies – and the FDA. FDA announced last … Continue reading “A Drug Recall That Should Frighten Us All About The FDA – Forbes”